(Q48948077)

17 February 2018

title

Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography. (English)

1 reference

17 February 2018

1 reference

1

1 reference

17 February 2018

author name string

M Kuoppamäki

2

1 reference

17 February 2018

K Någren

3

1 reference

17 February 2018

J Bergman

4

1 reference

17 February 2018

E Eronen

5

1 reference

17 February 2018

E Syvälahti

6

1 reference

17 February 2018

J Hietala

7

1 reference

17 February 2018

publication date

1 August 1996

1 reference

17 February 2018

published in

Psychopharmacology

1 reference

17 February 2018

volume

126

1 reference

17 February 2018

page(s)

277-280

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02247377

exact match

0 references

cites work

Fluoxetine and side effects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02247377

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02247377

Extrapyramidal symptoms with selective serotonin reuptake inhibitors

21 January 2018

1 reference

12 December 2020

Serotonin-dopamine interactions in the nigrostriatal system

1 reference

12 December 2020

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

12 December 2020

Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence

1 reference

12 December 2020

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.

1 reference

12 December 2020

Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact

1 reference

12 December 2020

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

12 December 2020

On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum

1 reference

12 December 2020

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

1 reference

12 December 2020

Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons

1 reference

12 December 2020

Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders

1 reference

12 December 2020

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

1 reference

12 December 2020

Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor

1 reference

12 December 2020

A Comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding

1 reference

12 December 2020

5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02247377

1 reference

17 February 2018

PubMed ID

8878342

1 reference

17 February 2018